Regulations.gov document
Interim Response to Covington & Burling LLP from FDA CDER
Other · FDA-2020-P-2322 · posted Jun 24, 2021
Key facts
| Document ID | FDA-2020-P-2322-0003 |
|---|---|
| Title | Interim Response to Covington & Burling LLP from FDA CDER |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-2020-P-2322 |
| Posted | Jun 24, 2021 |
| Comment period opens | Jun 24, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: